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Medicine and Genetics: Determining a Good Fit 
 
CEDARVILLE, OHIO -- Society has come a long way when it comes to medicine. New research comes 
out almost daily about the benefits of certain drug or treatment options. But sometimes a patient’s 
genetics are the greatest barrier to treatment success. 
  
There’s a doctor in Pennsylvania working to solve this issue. 
  
After graduating with a Pharm.D. from Cedarville University in 2018, Dr. Ryley Uber has been studying 
how genes affect a person’s response to certain drugs, otherwise known as pharmacogenomics. The 
new field combines the study of drugs (pharmacology) with the study of genes (genomics). 
  
Uber is currently working on a project about stents, tubes inserted into a blood vessel after a heart 
attack to keep it open. His research and clinical practice investigates if a patient with a stent has a gene 
variant that will interfere with a certain blood-thinning medication that is commonly prescribed. The 
research and recommendations enable medical professionals to better recommend treatment options 
for patients. 
  
Uber has been a fellow at the new Pharmacogenomics Center of Excellence at the University of 
Pittsburgh in Pittsburgh, Pennsylvania, since July 1, 2018. His fellowship is primarily research-based. 
Along with his research, Uber has published a textbook chapter update with mentor Dr. Philip Empey 
about his genotyping work. 
  
Uber is also involved in a separate research project where patients at the University of Pittsburgh 
Medical Center (UPMC) may give a blood sample that is tested genetically to predict responses to many 
medications. Including additional samples from locations in and around central Pennsylvania, at least 
150,000 samples will be collected with genetic results returned to patients, pharmacists and doctors. 
  
During his time at Cedarville, Uber secured a prestigious internship with the U.S. Food and Drug 
Administration (FDA) at the National Center for Toxicological Research (NCTR). He continues to 
collaborate with NCTR with his current research. 
  
“One of the biggest ways that Cedarville has helped me prepare for my career was in developing me 
clinically for what I’ve been engaging with,” said Uber. “They prepared me more than adequately to 
practice pharmacy. The faculty pushed me scientifically and helped me hone in on my research skills.” 
  
“On the first day of pharmacogenomics class, Ryley had a big smile on his face when I asked the students 
who was interested in using this stuff to create disruptive change in the pharmacy world of personalized 
approaches to treat patients,” said Dr. Rocco Rotello, associate professor of pharmaceutical sciences. 
“He has demonstrated character and gained knowledge to become an expert in this field by taking on 
challenging new hurdles and the willingness to answer critics that believe this new field of pharmacy is 
not relevant.” 
  
Located in southwest Ohio, Cedarville University is an accredited, Christ-centered, Baptist institution 
with an enrollment of 4,193 undergraduate, graduate and online students in more than 150 areas of 
study. Founded in 1887, Cedarville is recognized nationally for its authentic Christian community, 
rigorous academic programs, strong graduation and retention rates, accredited professional and health 
science offerings and leading student satisfaction ratings. For more information about the University, 
visit www.cedarville.edu. 
 
